General Information of Drug (ID: DM5WDKY)

Drug Name
TAS-103 Drug Info
Cross-matching ID
PubChem CID
135413533
ChEBI ID
CHEMBL488755
CAS Number
CAS 174634-08-3
TTD Drug ID
D0E2LA
INTEDE Drug ID
DR1813

Consensus Signature of Drug Pharmacogenomic Perturbation (DPP)

Term Name NES FDR q-val Tag % Leading Edge Genes
Epstein-Barr virus infection 2.50 0.00e+0 189/202 (93.56%) CDKN1A;DDB2;ISG15;...
p53 signaling pathway 2.37 0.00e+0 63/73 (86.3%) CDKN1A;SESN1;DDB2;...
Herpes simplex virus 1 infection 2.26 0.00e+0 165/498 (33.13%) FAS;IRF9;BAX;...
Graft-versus-host disease 2.18 0.00e+0 32/42 (76.19%) FAS;HLA-B;IL1B;...
Influenza A 2.14 0.00e+0 156/172 (90.7%) TNFRSF10B;FAS;IRF9;...
Measles 2.12 0.00e+0 133/139 (95.68%) FAS;IRF9;BAX;...
Lysosome 2.11 0.00e+0 115/128 (89.84%) FUCA1;AP1S2;TPP1;...
Kaposi sarcoma-associated herpesvirus infection 2.11 0.00e+0 172/193 (89.12%) CDKN1A;FAS;IRF9;...
Small cell lung cancer 2.10 0.00e+0 90/92 (97.83%) CDKN1A;DDB2;BAX;...
Viral myocarditis 2.05 0.00e+0 53/60 (88.33%) HLA-B;CXADR;HLA-F;...
Hepatitis C 2.02 0.00e+0 139/157 (88.54%) CDKN1A;FAS;IRF9;...
C-type lectin receptor signaling pathway 1.99 0.00e+0 93/104 (89.42%) EGR2;IRF9;RELB;...
NF-kappa B signaling pathway 1.95 2.65e-3 90/104 (86.54%) RELB;GADD45A;TNFAIP3;...
Viral protein interaction with cytokine and cytokine re... 1.92 4.10e-3 84/100 (84%) TNFRSF10B;CCL20;CXCL13;...
Type I diabetes mellitus 1.91 3.82e-3 38/43 (88.37%) FAS;HLA-B;IL1B;...
Apoptosis 1.89 4.30e-3 126/168 (75%) TNFRSF10B;FAS;BAX;...
Cytosolic DNA-sensing pathway 1.89 4.05e-3 52/63 (82.54%) IRF7;IL1B;NFKBIA;...
Allograft rejection 1.87 4.46e-3 32/38 (84.21%) FAS;HLA-B;HLA-F;...
Autoimmune thyroid disease 1.86 4.23e-3 46/53 (86.79%) FAS;HLA-B;HLA-F;...
Pancreatic cancer 1.86 4.02e-3 75/76 (98.68%) CDKN1A;DDB2;BAX;...
Cytokine-cytokine receptor interaction 1.86 3.82e-3 246/295 (83.39%) TNFRSF10B;FAS;IL32;...
TNF signaling pathway 1.85 4.17e-3 103/112 (91.96%) FAS;TNFAIP3;JAG1;...
Th1 and Th2 cell differentiation 1.85 3.99e-3 80/92 (86.96%) STAT1;JAG1;NFKBIA;...
Hematopoietic cell lineage 1.83 4.78e-3 90/99 (90.91%) CD9;IL1B;CD55;...
Melanoma 1.83 4.59e-3 68/72 (94.44%) CDKN1A;DDB2;BAX;...
Basal cell carcinoma 1.83 4.41e-3 41/63 (65.08%) CDKN1A;DDB2;BAX;...
Non-small cell lung cancer 1.81 6.37e-3 70/72 (97.22%) CDKN1A;DDB2;BAX;...
Inflammatory bowel disease 1.80 6.15e-3 58/65 (89.23%) STAT1;IL1B;MAF;...
RIG-I-like receptor signaling pathway 1.80 6.33e-3 64/70 (91.43%) ISG15;IRF7;NFKBIA;...
Th17 cell differentiation 1.79 6.12e-3 95/107 (88.79%) STAT1;IL1B;NFKBIA;...
mRNA surveillance pathway -1.66 4.68e-2 71/98 (72.45%) ACIN1;PPP2R5E;PPP2R5A;...
Protein processing in endoplasmic reticulum -1.68 4.49e-2 127/171 (74.27%) RPN1;MAN1A2;SEC24B;...
Cysteine and methionine metabolism -1.68 4.99e-2 43/50 (86%) CTH;LDHB;BCAT1;...
Ribosome biogenesis in eukaryotes -1.81 1.23e-2 52/108 (48.15%) BMS1;IMP4;GAR1;...
Cell cycle -1.89 7.00e-3 110/124 (88.71%) TGFB1;CDKN2A;CREBBP;...
DNA replication -1.94 5.45e-3 34/36 (94.44%) POLD1;MCM4;RNASEH2B;...
Nitrogen metabolism -1.98 6.54e-3 16/17 (94.12%) CA3;CA4;CA9;...
Oocyte meiosis -2.00 4.09e-3 90/129 (69.77%) ITPR2;RPS6KA6;CALML4;...
Progesterone-mediated oocyte maturation -2.06 0.00e+0 75/100 (75%) MAPK14;CDC23;CCNB1;...
RNA transport -2.12 0.00e+0 128/186 (68.82%) EIF2S2;EIF2S3;NUP62;...
Spliceosome -2.64 0.00e+0 101/150 (67.33%) HNRNPU;SART1;HNRNPK;...
×

Pharmacogenomic Perturbation Across Diseases and Tissues

Breast
Breast adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
MCF7 CVCL_0031 Homo sapiens 0.01uM - 10uM 24H
Cervix
Cervical adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HeLa CVCL_0030 Homo sapiens 0.01uM - 10uM 3H, 24H
Colon
Colorectal adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HT-29 CVCL_0320 Homo sapiens 0.01uM - 10uM 24H
Kidney
Normal (Immortalized)
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HA1E CVCL_0284 Homo sapiens 0.01uM - 10uM 24H
Lung
Lung adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
A549 CVCL_0023 Homo sapiens 0.01uM - 10uM 24H
Pancreas
Pancreatic carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
YAPC CVCL_1791 Homo sapiens 0.01uM - 10uM 24H
Prostate
Prostate carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
PC-3 CVCL_0035 Homo sapiens 0.01uM - 10uM 24H
Skin
Melanoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
A-375 CVCL_0132 Homo sapiens 0.01uM - 10uM 24H